At the news
? NEUTRALIMPACT 3/10 144 filed Nov 5, 2026 at 16:27 ET
CEO Peter Anevski filed a Form 144 notice of intent to sell 314,738 shares of Progyny common stock, valued at approximately $9.47 million based on the filing date. The shares are to be received upon exercise of stock options over the next three months, with the sale intended to occur on or after November 5, 2026.
- CEO Peter Anevski filed Form 144 to sell 314,738 shares of common stock
- Estimated aggregate value of shares: $9,473,613.80
- Shares to be acquired via exercise of stock options over the next three months
- Sale intended to occur on or after November 5, 2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access